what is trump's pharma deal

Donald Trump’s 'pharma deal' generally refers to his administration’s 2020 executive orders and the 'Most Favored Nation' rule aimed at tying U.S. Medicare drug prices to lower international reference prices. The measures were later paused and replaced by the Inflation Reduction Act’s negotiation framework under the Biden administration.